Waters Corporation ( WAT ) Nowojorska Giełda Papierów Wartościowych

Cena: 354.44 ( 1.27% )

Aktualizacja 06-26 21:45
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Diagnostics & Research
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Diagnostics & Research
Zatrudnienie: 7 900
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 100%
Ilość akcji: 59 127 000
Debiut giełdowy: 1995-11-17
WWW: https://www.waters.com
CEO: Dr. Udit Batra Ph.D.
Adres: 34 Maple Street
Siedziba: 01757 Milford
ISIN: US9418481035
Opis firmy:

Waters Corporation, firma specjalistyczna, zapewnia rozwiązania analityczne przepływu pracy w Azji, obu Amerykach i Europie. Działa przez dwa segmenty, wody i TA. Firma projektuje, produkuje, sprzedaje i obsługuje wysoką i ultra-wydajną cieczową chromatografię, a także systemy technologiczne spektrometrii masowej (MS), w tym kolumny chromatograficzne, inne produkty konsumpcyjne i plany usług po wojnie. Projektuje również, produkuje, sprzedaje i obsługuje analiza termiczna, reometria i instrumenty kalorymetrii; oraz opracowuje i dostarcza produkty oprogramowania, które łączą się z instrumentami, a także instrumentów innych producentów. Instrumenty technologiczne MS są wykorzystywane w odkrywaniu i rozwoju leków obejmujących badania badań klinicznych, analizę białek w procesach chorobowych, analizę bezpieczeństwa żywieniowego i testy środowiskowe. Firma oferuje instrumenty analizy termicznej, reometrii i kalorymetrii do stosowania w przewidywaniu przydatności i stabilności drobnych chemikaliów, farmaceutyków, wody, polimerów, metali i lepkich płynów do różnych produktów przemysłowych, konsumenckich i opieki zdrowotnej, a także do badań naukowych. Jego produkty są wykorzystywane przez Life Science, Pharmaceutical, Biochemical, Industrial Bezpieczeństwo, Bezpieczeństwo żywieniowe, środowiskowe, akademickie i rządowe pracujące w badaniach i rozwoju, zapewnieniu jakości i innych zastosowaniach laboratoryjnych. Waters Corporation został założony w 1958 roku i ma siedzibę w Milford, Massachusetts.

Wskaźniki finansowe
Kapitalizacja (USD) 21 092 405 404
Aktywa: 4 511 620 000
Cena: 354.44
Wskaźnik Altman Z-Score: 9.2
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 32.1
Ilość akcji w obrocie: 100%
Średni wolumen: 538 824
Ilość akcji 59 509 100
Wskaźniki finansowe
Przychody TTM 2 905 147 000
Zobowiązania: 2 908 521 000
Przedział 52 tyg.: 279.24 - 423.56
Piotroski F-Score: 5
Umiarkowany (średnia jakość finansowa)
EPS: 11.0
P/E branży: 30.3
Beta: 0.973
Raport okresowy: 2025-07-29
WWW: https://www.waters.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Keeley A. Aleman Senior Vice President, General Counsel & Corporate Secretary 897 333 1977
Mr. Amol Chaubal Senior Vice President & Chief Financial Officer 635 665 1977
Ms. Jianqing Y. Bennett Senior Vice President of TA Instruments Division & Waters Clinical Business Unit 621 092 1970
Dr. Udit Batra Ph.D. President, Chief Executive Officer & Director 1 166 944 1971
Caspar Tudor Director of Investor Relations 0 0
Mr. Robert L. Carpio III Senior Vice President of Waters Division 0 0
Ms. Kristen Garvey Vice President of Corporate Communications 0 0
Dr. Daniel Rush Ph.D. Senior Vice President of Strategy & Transformation 0 0
Mr. Christos Ross Senior Vice President of Global Operations 0 0
Mr. Patrick Conway Interim Vice President of Human Resources 0 0
Wiadomości dla Waters Corporation
Tytuł Treść Źródło Aktualizacja Link
Waters Corporation to Present at the Jefferies Global Healthcare Conference MILFORD, Mass. , May 16, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D. prnewswire.com 2025-05-16 15:00:00 Czytaj oryginał (ang.)
Waters Corp's India business boosted by rush for weight-loss drugs U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a senior executive told Reuters. reuters.com 2025-05-15 11:48:58 Czytaj oryginał (ang.)
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y WAT's first-quarter 2025 results reflect strong growth in the instruments and chemical segments, coupled with strong momentum in the industrial and pharma sectors. zacks.com 2025-05-07 17:45:41 Czytaj oryginał (ang.)
Waters Corporation: Still A Hold After Q1 Earnings Waters Corporation's stock remains a "Hold" due to high valuation multiples, despite a 35% increase in stock price and improved business performance. The company reported solid Q1 2025 results, with 3.9% revenue growth and 18% EPS growth, but valuation remains above historical averages. Management is optimistic about future growth, citing opportunities in the Indian market, GLP-1 testing, and pricing strategies, expecting high single-digit revenue growth. seekingalpha.com 2025-05-06 20:20:11 Czytaj oryginał (ang.)
Waters Corporation (WAT) Q1 2025 Earnings Call Transcript Waters Corporation (NYSE:WAT ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer Amol Chaubal - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research LLC Tycho Peterson - Jefferies Puneet Souda - Leerink Partners Catherine Schulte - Robert W. Baird & Co. Sung Ji Nam - Scotiabank Global Banking and Markets Brandon Couillard - Wells Fargo Securities LLC Vijay Kumar - Evercore ISI Matthew Sykes - Goldman Sachs Group, Inc. Daniel Arias - Stifel, Nicolaus & Company Daniel Brennan - TD Cowen Operator Good morning. seekingalpha.com 2025-05-06 15:57:33 Czytaj oryginał (ang.)
Waters (WAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-05-06 15:00:40 Czytaj oryginał (ang.)
Waters (WAT) Q1 Earnings and Revenues Beat Estimates Waters (WAT) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.21 per share a year ago. zacks.com 2025-05-06 12:10:32 Czytaj oryginał (ang.)
Waters raises 2025 profit forecast on resilient demand for lab equipment Waters raised its annual profit forecast on Tuesday, after reporting better-than-expected first quarter results due to higher demand for its medical instruments in Asia and the Americas. reuters.com 2025-05-06 11:21:06 Czytaj oryginał (ang.)
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance News Summary  Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques.3 MILFORD, Mass. , May 6, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that its Empower™ Software now supports biologics data acquisition and quality control (QC) analysis from Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments in its Wyatt Technology™ Portfolio. prnewswire.com 2025-05-06 10:15:00 Czytaj oryginał (ang.)
Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currency Results led by instrument growth of 11% in constant currency, driven by strong momentum in Pharma and Industrial end markets Earnings landed at the high-end of guidance range with GAAP EPS of $2.03 and non-GAAP EPS of $2.25 Raising full-year constant currency sales growth guidance to +5.0% to +7.0%, given first quarter strength Raising full-year non-GAAP EPS guidance to the range of $12.75 to $13.05, net of tariff impact, operational actions, and improvement in FX First Quarter 2025 MILFORD, Mass. , May 6, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT), today announced its financial results for the first quarter of 2025. prnewswire.com 2025-05-06 10:00:00 Czytaj oryginał (ang.)
Is Carnival About to Sail Into Rough Waters? Investors may suddenly feel confused about Carnival (CCL 4.91%) stock. Both Carnival and its largest competitors, Royal Caribbean and Norwegian Cruise Line Holdings, had previously stuck to bullish forecasts as bookings remained strong despite sluggishness in the market. fool.com 2025-05-05 09:12:00 Czytaj oryginał (ang.)
What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q1 Earnings Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2025-05-01 14:20:50 Czytaj oryginał (ang.)
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetrated markets with potential FDA approval for Thunderbolt device as a growth catalyst. seekingalpha.com 2025-04-29 15:45:00 Czytaj oryginał (ang.)
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-04-29 15:06:52 Czytaj oryginał (ang.)
Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report? Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com 2025-04-25 17:15:35 Czytaj oryginał (ang.)
Waters Corporation Schedules First Quarter 2025 Earnings Conference Call MILFORD, Mass. , April 8, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2025 financial results conference call on Tuesday, May 6th, 2025 at 8:00 a.m. prnewswire.com 2025-04-08 20:30:00 Czytaj oryginał (ang.)
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC News Summary Boosts out-of-the-box sensitivity by up to 80 times with MaxPeakTM Premier columns.1 Delivers over threefold improvements in day-to-day reproducibility2 and decreases carryover by up to two orders of magnitude.3 Reduces common user errors by up to 40%.4 MILFORD, Mass. , April 1, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the expansion of the Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection, advancing the capabilities of the next-generation intelligent HPLC platform designed for development and Quality Control (QC) laboratories. prnewswire.com 2025-04-01 12:00:00 Czytaj oryginał (ang.)
BP and SOCAR Enter Israeli Waters With Gas Exploration Deal BP and SOCAR secure offshore gas licenses in Israel, a strategic move as Israel strengthens its role in the global energy market and expands natural gas exports. zacks.com 2025-03-18 12:40:50 Czytaj oryginał (ang.)
Winnebago Is Still Facing Choppy Waters Winnebago Industries, Inc. is still trying to navigate a massive downturn in the RV and boating industry over the past couple of years. The company's earnings skyrocketed from $3.52/share in 2019 to $11.82/share in 2022, but have since plummeted since then. Winnebago is making smart moves to adjust to macroeconomic conditions, but it hasn't been enough to offset the huge decline in demand. seekingalpha.com 2025-03-17 17:02:09 Czytaj oryginał (ang.)
Waters Corporation to Present at the Leerink Partners Global Healthcare Conference MILFORD, Mass. , March 7, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D. prnewswire.com 2025-03-07 15:00:00 Czytaj oryginał (ang.)
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern Waters Corp reported better-than-expected Q4'24 and FY'24 results, driven by strong performance in academia, government, and pharma segments, despite FX headwinds impacting gross margins. The company anticipates continued growth in 2025, with projected revenue growth between 4.5% and 7%, supported by emerging markets like India and high-growth areas like GLP-1 and PFAS testing. Risks include elevated valuations and limited opportunities for cash deployment, making buybacks less attractive; current valuation appears challenging compared to historical averages and peers. seekingalpha.com 2025-02-21 06:21:41 Czytaj oryginał (ang.)
WAT Earnings & Sales Surpass Estimates in Q4, Shares Rise WAT's fourth-quarter 2024 results reflect strong pharma growth and robust gains across all regions. However, forex headwinds hurt. zacks.com 2025-02-13 15:25:18 Czytaj oryginał (ang.)
Waters Corporation (WAT) Q4 2024 Earnings Call Transcript Waters Corporation (NYSE:WAT ) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President & Chief Executive Officer Amol Chaubal - Senior Vice President & Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - Leerink Eve Burstein - Bernstein Brandon Couillard - Wells Fargo Dan Arias - Stifel Dan Brennan - TD Cowen Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Fourth Quarter 2024 Financial Results Conference Call. seekingalpha.com 2025-02-12 15:28:09 Czytaj oryginał (ang.)
Waters (WAT) Q4 Earnings and Revenues Top Estimates Waters (WAT) came out with quarterly earnings of $4.10 per share, beating the Zacks Consensus Estimate of $4.02 per share. This compares to earnings of $3.62 per share a year ago. zacks.com 2025-02-12 10:16:07 Czytaj oryginał (ang.)
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in constant currency, as growth accelerated across all three reported regions Pharma grew 10% in constant currency, reflecting stronger-than-expected year-end spending dynamics and broad-based growth across the Americas, Europe, and Asia GAAP EPS of $3.88; non-GAAP EPS of $4.10 grew 13% as strong operational performance and better-than-expected sales volume offset foreign exchange headwinds Full-Year 2024 Sales exceeded guidance at $2,958 million, flat as reported and in organic constant currency GAAP operating income margin of 27.9%; operational excellence drove adjusted operating income margin expansion to 31.0%, effectively neutralizing the challenges posed by foreign exchange headwinds GAAP EPS of $10.71; non-GAAP EPS of $11.86 grew 1% versus 2023, which includes a 5% impact due to foreign exchange headwinds Generated $762 million in operating cash flow; $744 million in free cash flow, representing 25% of full-year sales, and a free cash flow to adjusted net income ratio of 105% MILFORD, Mass. , Feb. 12, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced its financial results for the fourth quarter and full-year 2024. prnewswire.com 2025-02-12 08:00:00 Czytaj oryginał (ang.)
Waters ElectroForce Apex 1 Instrument Offers Increased Versatility, Simplicity, and Speed to Mechanical Testing of Advanced Polymer Materials News Summary: Offers increased versatility and data-driven insights with 43% greater motor stroke range (100 mm),1 expanding testing to more materials across diverse industries. Improved dynamic performance completes fatigue testing up to 30% faster than the competition,2 increasing the speed of product development and validation. prnewswire.com 2025-02-04 10:00:00 Czytaj oryginał (ang.)
Weighing In On Waters Corporation: Facing A Valuation Headwind Today, we take a more in-depth look at Waters Corporation, which provides analytical workflow solutions, primarily to the Pharma and Industrial industries. WAT stock has surged 35% since July lows, but analysts are growing increasingly cautious due to valuation concerns, with mixed ratings and tepid price targets. From a historical perspective, the equity now trades at the very top of its historical P/S and P/E ratios. seekingalpha.com 2025-01-29 11:20:24 Czytaj oryginał (ang.)
Innovative Waters TGA Smart-Seal Pans Enable Lower Cost, More Efficient Benchtop Analysis of Atmosphere-Sensitive Materials News Summary: New and proprietary product enabling laboratories to analyze atmosphere-sensitive materials used to develop batteries, advanced polymers, and medicines in a standard laboratory benchtop-installed thermogravimetric analyzer (TGA). Reduces the cost and footprint of the TGA system by up to 50%i by helping eliminate the need for environment-controlled housing, or glovebox. prnewswire.com 2025-01-22 10:00:00 Czytaj oryginał (ang.)
Waters Corporation Schedules Fourth Quarter 2024 Earnings Conference Call MILFORD, Mass. , Jan. 17, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2024 financial results conference call live on Wednesday, February 12th, 2025 at 8:00 a.m. prnewswire.com 2025-01-17 16:48:00 Czytaj oryginał (ang.)
Waters Corporation to Host Investor Day on March 5, 2025 MILFORD, Mass. , Jan. 10, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that it will host an Investor Day on Wednesday, March 5th, 2025, in New York City, starting at 8:30 AM ET. prnewswire.com 2025-01-10 16:30:00 Czytaj oryginał (ang.)
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain? TECH enters a co-marketing and co-promotion agreement with Waters Corporation to expand the reach of advanced biotherapeutic characterization and development processes. zacks.com 2024-12-23 11:05:23 Czytaj oryginał (ang.)
Waters Corporation Named to Dow Jones Sustainability Index for the Fourth Consecutive Year MILFORD, Mass. , Dec. 23, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the fourth consecutive year, based on the strength of its enterprise-wide sustainability practices. prnewswire.com 2024-12-23 10:19:00 Czytaj oryginał (ang.)
Waters Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference MILFORD, Mass. , Dec. 17, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D. prnewswire.com 2024-12-17 13:00:00 Czytaj oryginał (ang.)
Waters Highlights Continued Progress Towards Sustainability Commitments News Summary: Exceeded its goal of reducing Scope 1 and 2 greenhouse gas emissions by 36% from a 2016 baseline, two years ahead of schedule. Invested in STEM education through the Waters Student Academy and Waters internship program, reaching hundreds of students with hands-on learning opportunities. prnewswire.com 2024-12-10 10:00:00 Czytaj oryginał (ang.)
Elf Beauty says short-seller Muddy Waters' allegations are 'without merit' Elf Beauty said on Thursday allegations by short-seller Muddy Waters about the beauty company overstating its revenue and inventory numbers were "without merit". reuters.com 2024-11-21 10:22:41 Czytaj oryginał (ang.)
Muddy Waters CEO Carson Block Says He's Shorting Elf Beauty Muddy Waters' Carson Block says he's shorting Elf Beauty Inc. as he thinks the cosmetics brand has overstated revenue in recent quarters and that a build up in the beauty company's inventory was due to lackluster sales. Elf Beauty's shares fell 16% after the announcement. youtube.com 2024-11-21 09:26:52 Czytaj oryginał (ang.)
Elf Beauty stock slides after Muddy Waters says it has shorted its shares Muddy Waters has taken a short position in cosmetics company Elf Beauty , the hedge fund's chief executive Carson Block said at the Sohn conference in London on Wednesday. reuters.com 2024-11-20 16:36:19 Czytaj oryginał (ang.)
Muddy Waters' Carson Block Bets Against E.L.F. Beauty: Short Seller Says Retailer's Financials Show 'Major Red Flag' Muddy Waters Research founder Carson Block announced a new short position in E.l.f. Beauty, Inc ELF at the Sohn conference on Wednesday, which sent shares of the cosmetics company tumbling. benzinga.com 2024-11-20 16:31:31 Czytaj oryginał (ang.)
Waters Corporation to Present at the Evercore 2024 HealthCONx Conference MILFORD, Mass. , Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D. prnewswire.com 2024-11-20 16:00:00 Czytaj oryginał (ang.)
Why Muddy Waters' CIO Carson Block is skeptical of e.l.f. Beauty Carson Block, founder and CIO of Muddy Waters Research, joins CNBC's 'The Exchange' to discuss why his firm is shorting e.l.f. Beauty, why he believes the company may be lying about some of its data, and more. youtube.com 2024-11-20 15:59:24 Czytaj oryginał (ang.)
Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufacturing footprint while increasing precision machining and metrology capacity to support future growth. prnewswire.com 2024-11-13 10:00:00 Czytaj oryginał (ang.)
Confluence's Revolution solution recognized as Best Buy-side Risk Management Initiative by Waters Technology PITTSBURGH--(BUSINESS WIRE)--Confluence Technologies, Inc. (“Confluence”), a global technology solutions provider for regulatory, analytics, and investor communications solutions for the investment management industry, proudly announced that its Revolution solution for multi-asset performance, attribution and risk analytics, has been named Best Buy-side Risk Management Initiative in the Last 12 Months by Waters Technology's Buy-side Technology Awards, marking the fourth time Confluence has won. businesswire.com 2024-11-08 06:30:00 Czytaj oryginał (ang.)
Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation. Cloud-based software proactively provides visibility into risks that could trigger adverse regulatory findings, delivering seamless remote data access, comprehensive analytics, historical trends, scalability, and cost efficiency. prnewswire.com 2024-11-07 10:00:00 Czytaj oryginał (ang.)
Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View WAT's third-quarter 2024 results show growth in the pharma and industrial sectors. A dip in China sales creates headwinds. zacks.com 2024-11-04 15:40:16 Czytaj oryginał (ang.)
Artificial Intelligence Risk Inc. Named as Waters Technology's "Best buy-side AI platform or tool (compliance)" for the AIR- GPT Gen AI Platform Waters Technology Recognizes Generative-AI Platform Focused on Compliance and Cybersecurity Greenwich, Connecticut--(Newsfile Corp. - November 4, 2024) - Artificial Intelligence Risk, Inc. (AI Risk, Inc.), the leader in Gen AI compliance and cybersecurity software, today announced its recognition as the best buy-side AI platform or tool (compliance) by WaterTechnology's 2024 Buy-Side Technology Awards. This acknowledgement, awarded as AI Risk, Inc. is growing rapidly in terms of both clients and staff, underscores the company's rapid and exceptional impact on the financial industry. newsfilecorp.com 2024-11-04 12:22:00 Czytaj oryginał (ang.)
Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates Shares of Waters Corp. (WAT) surged nearly 20% on Friday, delivering the top daily performance in the S&P 500 after the company reported third-quarter sales and earnings that topped analysts' projections. investopedia.com 2024-11-01 20:05:49 Czytaj oryginał (ang.)
S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve Following a pair of negative trading sessions, major U.S. equities indexes closed out the week on a strong note, pushing higher on Friday as investors cheered upbeat earnings results from e-commerce and cloud computing behemoth Amazon (AMZN). investopedia.com 2024-11-01 20:05:47 Czytaj oryginał (ang.)
Waters Corporation (WAT) Q3 2024 Earnings Call Transcript Waters Corporation (NYSE:WAT ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Caspar Tudor – Head of Investor Relations Udit Batra – President and Chief Executive Officer Amol Chaubal – Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson – Jefferies Brandon Couillard – Wells Fargo Puneet Souda – Leerink Partners Vijay Kumar – Evercore ISI Dan Brennan – TD Cowen Matt Sykes – Goldman Sachs Operator Good morning, and welcome to the Waters Corporation Third Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session begins. seekingalpha.com 2024-11-01 14:47:01 Czytaj oryginał (ang.)
Waters (WAT) Beats Q3 Earnings and Revenue Estimates Waters (WAT) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.84 per share a year ago. zacks.com 2024-11-01 10:11:15 Czytaj oryginał (ang.)
Waters Corp raises annual profit forecast on higher demand for lab equipment Waters Corp raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug development and research. reuters.com 2024-11-01 08:43:48 Czytaj oryginał (ang.)